Determination of antituberculosis drug concentration in human plasma by MALDI-TOF/TOF

IUBMB Life

Volumn 62, Issue 5, 2010, Pages 387-393

  Notari, Stefania ^a   Mancone, Carmine ^a   Sergi, Manuel ^b   Gullotta, Francesca ^c   Bevilacqua, Nazzario ^a   Tempestilli, Massimo ^a   Urso, Rocco ^a   Lauria, Francesco Nicola ^a   Pucillo, Leopoldo Paolo ^a   Tripodi, Marco ^a,d   Ascenzi, Paolo ^a,c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF TERAMO   (Italy)

^c ROMA TRE UNIVERSITY   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antituberculosis drug determination; Human plasma; MALDI TOF TOF

Indexed keywords

4 HYDROXYBENZOIC ACID; ACETONITRILE; ETHAMBUTOL; FORMIC ACID; NITROGEN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TRIFLUOROACETIC ACID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG MONITORING; ETHAMBUTOL; HUMANS; PYRAZINAMIDE; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTOMYCIN;

EID: 77953581278     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.321     Document Type: Article

References (16)

1. Joint HIV/Tuberculosis Interventions, World Health Organization (2010) Available at http://www.who.int/hiv/topics/tb/tuberculosis/en/.
2. du Toit, L. C., Pillay, V., and Danckwerts, M. P. (2006) Tuberculosis chemotherapy: current drug delivery approaches. Respir. Res. 7, 118.
3. Potter, B., Rindfleisch, K., Kraus, C. K. (2005) Management of active tuberculosis. Am. Fam. Physician 72, 2225-2232.
4. Furin, J. (2007) The clinical management of drug-resistant tuberculosis. Curr. Opin. Pulm. Med. 13, 212-217.
5. Peloquin, C. A. (2002) Therapeutic drug monitoring in the treatment of tuberculosis. Drugs 62, 2169-2183.
6. Notari, S., Mancone, C., Tripodi, M., Narciso, P., Fasano, M., and Ascenzi P. (2006) Determination of anti-HIV drug concentration in human plasma by MALDI-TOF/TOF. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 833, 109-116.
7. Notari, S., Mancone, C., Aloni, T., Tripodi, M., Narciso, P., and Ascenzi, P. (2008) Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration in human plasma by MALDI-TOF/TOF. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 863, 249-257.
8. Bruce, G. R., and Gill, P. S. (1999) Estimates of precision in a standard additions analysis. J. Chem. Educ. 76, 805-807.
9. Guidance for Industry: Bioanalytical Method Evaluation (2001) Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM070107.pdf.
10. Shah, V. P. (2007) The history of bioanalytical method validation and regulation: evolution of a guidance document on bioanalytical methods validation. AAPS J. 9, E43-E47.
11. Shou, W. Z., and Naidong, W. (2005) Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825, 186-192.
12. Hartkoorn, R. C., Khoo, S., Back, D. J., Tjia, J. F., Waitt, C. J., Chaponda, M., Davies, G., Ardrey, A., Ashleigh, S., and Ward, S. A. (2007) A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 857, 76-82.
13. Song, S. H., Jun, S. H., Park, K. U., Yoon, Y., Lee, J. H., Kim, J. Q., and Song, J. (2007) Simultaneous determination of first-line antituberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21, 1331-1338.
14. Granja, R. H., Niño, A. M., Zucchetti, R. A., Niño, R. E., Patel, R., and Salerno, A. G. (2009) Determination of streptomycin residues in honey by liquid chromatographytandem mass spectrometry. Anal. Chim. Acta 637, 64-67.
15. Um, S. W., Lee, S. W., Kwon, S. Y., Yoon, H. I., Park, K. U., Song, J., Lee, C. T., and Lee, J. H. (2007) Low serum concentrations of antitu-berculosis drugs and determinants of their serum levels. Int. J. Tuberc. Lung Dis. 11, 972-978.
16. Drugs.com, Drug Information Online (2010) Available at http://www.drugs.com.